Adivo Associates LLC

We’re excited to welcome Rachel Sosalski as Principal on the Commercial Launch & Marketing Excellence team! Rachel has over 20 years of pharmaceutical marketing & commercial launch experience leading brands in the US as well as globally. In addition to her creative agency experience, she has also worked across various segments of the industry including Global Marketing, Channel, Trade & Distribution, Managed Markets, HCP & Patient Marketing, as well as Omnichannel excellence. With therapeutic area expertise spanning the Metabolic, CNS, Oncology, Dermatology, Respiratory, Vaccine, Urology & Women’s Health categories, Rachel is a great addition to our team. #lifeatherspiegel #pharma #biotech

Effective pre-launch planning is essential in rare disease markets. Read how we refined the client’s clinical narrative and strengthened its market position: https://lnkd.in/eryYqFK3 #MedicalAffairs #AskHerspiegel

If you are at JPM this week, let’s connect to discuss how to unlock the potential for your rare disease asset: 1. How are you leveraging specialty market insights to understand patient segmentation and prescribing centers? 2. Are you prepared for your next product launch with an integrated commercial strategy? 3. What’s your approach to payer engagement and patient support for sustainable product uptake and adherence? Schedule an in-person meeting with Ying Yang and Maik Klasen here: https://bit.ly/4aeToGK Looking forward to an inspiring JPM week filled with exciting opportunities and connections! #JPM #JPM2025 #Healthcare

If you are at JPM this week, let’s connect to discuss how to unlock the potential for your rare disease asset: 🔹 How are you leveraging specialty market insights to understand patient segmentation and prescribing centers? 🔹 Are you prepared for your next product launch with an integrated commercial strategy? 🔹 What’s your approach to payer engagement and patient support for sustainable product uptake and adherence? Schedule an in-person meeting with Ying Yang and Maik Klasen here: https://lnkd.in/eEZD3Rnf Looking forward to an inspiring JPM week filled with exciting opportunities and connections!

3x greater data visibility, 30% fewer outbound calls, and 75% faster delivery—our redesigned patient HUB improved access and adherence for patients with complex conditions. Read here: https://lnkd.in/erY7pdgR #MarketingExcellence #PatientServices #AskHerspiegel

Scaling cell and gene therapies are complex, but essential for transformative impact. Streamlining development brings innovative treatments to patients more efficiently and at a larger scale. Hear from our expert Beth Schurman: https://lnkd.in/ewHzQGFP #LaunchExcellence #AskHerspiegel

First-to-market rare disease therapies demand strategic planning and collaboration. Unlock key insights on driving awareness, educating providers, and enhancing access. Hear from our experts Emily Philips and Ryan Subhan: https://lnkd.in/eTvsWpuW #MarketAccess #LaunchExcellence #AskHerspiegel

Success in rare disease markets isn't by chance—it's by design. Learn how strategic budgeting, planning, and precise timelines can ensure a seamless launch: https://lnkd.in/eA9JQfAc #MarketAccess #MedicalAffairs #LaunchExcellence #AskHerspiegel

Achieving commercial success starts early. Herspiegel ensures your launch is market-ready with strategic planning, adaptable forecasts, and expert insights that drive patient access. Hear from our expert Santosh Naik: https://lnkd.in/eeDeW7ih #LaunchExcellence #AskHerspiegel #CommercialReadiness

Wishing you a very Happy New Year! 2025 is full of new opportunities, fresh challenges, and endless possibilities, and we’re thrilled to continue this journey with all of you. Together, we’ll reach new heights, achieve greater milestones, and make an even bigger impact. Here’s to a year of growth and success. May the year ahead bring you happiness, prosperity, and countless moments to celebrate. #HappyNewYear #Welcome2025 #Gratitude #Growth #Teamwork #Innovation #NewYearNewGoals #AskHerspiegel